About: Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) wetenschappelijk artikel (nl) наукова стаття, опублікована у квітні 2011 (uk) im April 2011 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q58282415-757CCE04-417C-47D8-82A0-F988611F9B5E
publication date	2011-03-21 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58282415-310EF8DE-2794-4EA9-AF3A-8A9C3952B93A
language of work or name	English
author name string	wds:Q58282415-36FE022D-1BB1-4426-B408-3E256AA7D4B7 wds:Q58282415-48169823-8FC5-453F-9CBF-C10F013F862E wds:Q58282415-5A5B8CDA-C8F2-4E07-9A57-0C32C8AFB14D wds:Q58282415-828711B4-48D1-4068-891D-12869A917E2C wds:Q58282415-BB757338-E267-45AA-9E4C-859A4B4BF17C wds:Q58282415-DBF922BB-2A36-41E9-AB93-603C659AC753 wds:Q58282415-EF6FD85D-740E-4B47-8B57-AC4E8AC318EB
author name string	Roberta Ferraldeschi Malcolm Ranson Glen Clack Jian-Mei Hou Lynsey Priest Robert Sloane Tim H Ward
rdfs:label	Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer (en) Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer (nl)
skos:prefLabel	Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer (en) Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer (nl)
name	Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer (en) Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer (nl)
author	wds:Q58282415-13950C74-E014-4FE8-BF0C-7307946D069E wds:Q58282415-3129DF82-D849-45F3-A148-77A9E56A6783 wds:Q58282415-71ED132D-14AF-4CA2-846A-4173C7D0A7FF wds:Q58282415-76675A53-1A55-4D5A-B987-0C67DA39AF80 wds:Q58282415-D00AF8D7-1F43-4A5A-8F60-801D74C420C2 wds:Q58282415-FF9E46C5-BCAE-489C-B728-FE43F5EF3B90
author	Caroline Dive Fiona Blackhall Lee Lancashire Alastair Peter Greystoke Andrew Hughes Matthew G Krebs
title	wds:Q58282415-1FDF2F55-C6CF-4421-9489-3F527B08CE2A
title	Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer (en)
page(s)	wds:Q58282415-FD2B120E-2DDB-4281-8B3E-F3D52FB85669
page(s)	1556-1563
instance of	wds:Q58282415-3F8DEB03-AA49-4D75-95B7-E2751D91C648
instance of	scholarly article
main subject	wds:Q58282415-23EF937A-E214-4A44-98BF-A75412BEC463 wds:Q58282415-7343CAEF-BB31-4547-B102-864BC92E805C
main subject	lung cancer Patients
PubMed ID	wds:Q58282415-E4142A00-5175-4DBA-9F74-D83126C4D50E
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21422424
PubMed ID	21422424
published in	wds:Q58282415-90994023-B302-4082-A4BF-85BAD1A86A31
published in	Journal of Clinical Oncology
issue	wds:Q58282415-90CDAEBC-F877-4617-B599-53FF023A7F92
volume	wds:Q58282415-0F76421B-B6CA-4CBF-A528-E3F2E9CA8B25
issue	12
volume	29
DOI	wds:Q58282415-3CC95110-7937-430D-8321-266D8C01DB03
DOI	http://dx.doi.org/10.1200/JCO.2010.28.7045
DOI	10.1200/JCO.2010.28.7045
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58282415
is cites work of	Slanted spiral microfluidics for the ultra-fast, label-free isolation of circulating tumor cells Circulating tumor cells as lung cancer biomarkers Challenges in circulating tumor cell detection by the CellSearch system Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer. Circulating tumour cells as tumour biomarkers in melanoma: detection methods and clinical relevance Challenges in circulating tumour cell research Molecular analysis of circulating tumour cells-biology and biomarkers Biomarkers of cell death applicable to early clinical trials Prognostic and predictive biomarkers for targeted therapy in NSCLC: for whom the bell tolls? Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancer Characterization of different CTC subpopulations in non-small cell lung cancer Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment Strategies for modern biomarker and drug development in oncology Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial Circulating Tumor Cells: A Window Into Tumor Development and Therapeutic Effectiveness Blood-based Tumor Markers in Lung Cancer Quantification of rare circulating tumor cells in non-small cell lung cancer by ligand-targeted PCR. Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer. Interpretation of changes in circulating tumor cell counts. High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: a longitudinal analysis Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients Circulating tumour cells: their utility in cancer management and predicting outcomes Circulating tumor cell technologies Enrichment, detection and clinical significance of circulating tumor cells Beyond the Capture of Circulating Tumor Cells: Next-Generation Devices and Materials Comparison of Circulating Tumour Cells and Circulating Cell-Free Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy Circulating tumors cells as biomarkers: progress toward biomarker qualification Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software